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الٌبرغَ ػي الاصبثَ ثبلجكزرٗب  12إهكبً٘خ ًقص ف٘زبه٘ي ة 
 الحلزًَّ٘
 
  :ملخص الدراسه
 
 
زرٔ رؼر٘ت رحررذ اللجقرَ الو بط٘رَ هرري ثلبًرخ الوؼر ٍ الو ررجت ّال"  رؼزجرر الجكزرٗرب الحلزًّ٘رر  َ
ح٘ررش اى ً ررجخ . الاكضررر اًز رربيا فررٖ الؼرربلن  الوؼرر ٍ ّالاصٌررٔ ػ ررر لالزِرربة ّرقرررػ  الرئ٘ ررٖ
ثٌ٘وررب فررٖ الرر ّع %  70 -77الجكزرٗررب فررٖ اّع الؼرربلن الضبلررش ر رر  هرري  الاصرربثَ فررٖ ُرر  ٍ
كورب اى ُر ٍ الجكزرٗرب رزٗر  هري ه ربطر الاصربثَ ث ررطبى %.75-71الوزلْيٍ ر   هرب ثر٘ي 
 .الوؼ ٍ
ّٗؼرْا %  71 ػٌ  كجبي ال ي ٗجلر  اكضرر هري ) كْثبلو٘ي(12اى ً جخ ح ّس ًقص ف٘زبه٘ي ة
 ّالزرٔ رجلر  ً رجزَ  ب سرْ  الاهز ربو ّسرْ  الزه ٗر  َسجت ذلك الٌقص الٔ ػر ح ػْاهر  اُوِر 
 .الحبلادُ ٍ هي % 71-52 رجل  ً جزَ هي فقر ال م ال ج٘ش هي ُ ٍ الحبلاد اهب  % 76
اى الزِربة الوؼر ٍ الٌربرظ ػري الاصربثَ ثؼرر ّٓ الجكزرٗرب الحلزًّ٘رَ ّالزرٔ ثر ّيُب رر إ الررٔ 
ػري اًزربط الؼبهر  الر ايلٖ الر ٕ ٗ ربػ  و ر ّلَ ال )الجرر٘ربع (الغ ايٗرَ للوؼر ٍ   لاٗربالرر ه٘ر 
 .فٖ الغ ن  12اهز بو ف٘زبه٘ي ة ػلٔ
 
ػٌر  الاخر بو  12ُر ا ّدر  ّعر د ثؼرا ال ياسربد اى ٌُربن ػلادرَ ثر٘ي ًقرص ف٘زربه٘ي ة 
القضرب  ػلرٔ  در  ّعر  اى ثبلجكزرٗب الحلزًَّ٘ ّ الؼ ّٓبث٘ي ثبلزِبثبد الوؼ ٍ الٌبرحَ ػي  الو
 .فٖ ال م 12فٖ ً جخ ف٘زبه٘ي ة ُ ٍ الجكزرٗب ٗ إ الٔ ايرفبع
 
الؼلادررَ ثرر٘ي الزِرربة الوؼرر ٍ الٌبرغررَ ػرري  رح ٗرر  :ُررْ ٍ ال ياسررَاى الِرر ا الرئ٘ ررٖ هرري ُرر 
لاضربفَ الرٔ ػور  هقبيًرَ ثر٘ي بفرٖ الر م ث  12الاصبثَ ثبلجكزرٗرب الحلزًّ٘رَ ًّقرص ف٘زربه٘ي ة 
 .ٗبًزبلئظ الفحْصبد الو زلفَ الزٖ ر ز  م فٖ ر  ٘ص الاصبثَ ثِ ٍ الجكزر
 67هرٗا هوي ٗؼبًْى هي الام فٖ الوؼ ٍ رن ايز٘بيُن هي اص   76ّد  روذ ال ياسَ ػلٔ 
 :هرٗا رن اسزضٌب ُن ثٌب ا ػلٔ ػ ح ػْاه  ُٖ
 .الوؼرفَ ثْعْا فقر ال م ال ج٘ش -2
 .اعرا  ػول٘خ اسزئ بع للوؼ ٍ اّ عز  هٌِب -1  
 . 12الز إّ ثبلف٘زبه٘ي ة -3
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 َْٗالز إّ ثبلوضبااد الح٘-4
 .الحو  -5
 
 
 :ر ٘ر الٌزبئظ الو ز ل َ هي ُ ٍ ال ياسَ الٔ
ُّررٖ هرري % 17صرربثَ ثبلجكزرٗررب الحلزًّ٘ررَ فررٖ هغوْػررخ الجحررش ر رر  الررٔ اى ً ررجخ الا -2
 .الٌزبئظ الؼبلوَ٘
ػٌر  الورضرٔ % 16فٖ ُ ٍ الوغوْػرَ ر ر  اع  12اى ً جخ ح ّس ًقص فٖ ف٘زبه٘ي ة-1
 .ثبلجكزرٗب الحلزًَّ٘ الو بث٘ي 
 .ّايرفبع هزْسط حغن ال لاٗب الحورا  12اى ٌُبن ػلادَ ث٘ي ًقص ف٘زبه٘ي ة-3
لق  ثٌ٘ذ ال ياسَ اى الز ي٘ي ّ الغٌس لا ٗلؼجبى اّيا فرٖ يٗرباح الاصربثَ ثِر ٍ الجكزرٗرب ّ  -4
 .12ٗباح ً جخ ح ّس ًقص ف٘زبه٘ي ةيلا فٖ 
كزرٗررب الحلزًّ٘ررَ اى ُرر ٍ ال ياسررَ اربحررذ الفرصررَ لوقبيًررَ ر رر ٘ص الاصرربثَ ثبلج كوررب  -5
 .ثْاسلخ اعرا  رٌظ٘ر الوؼ ٍ  هغ الْسبئ  الايرٓ ّالزٖ رؼزو  الفحْصبد الو جرَٗ
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Helicobacter pylori, a potential causative agent 
of vitamin B12 deficiency. 
Abstract: 
Helicobacter pylori is considered to be the most common human 
pathogen colonizing the gastric mucosa of almost all people 
worldwide. It has been implicated in increasing the risk of developing 
gastric cancer which is the second most frequent cause of cancer-
related
 
deaths. The prevalence of Helicobacter pylori in the 
developing countries is 70 to 90% as compared to 20 to 50% in 
developed countries. The infection is believed to be acquired during 
childhood. 
Vitamin B12 or cobalamin deficiency occurs frequently (> 20%) 
among elderly people. Causes of the deficiency include food 
cobalamin malabsorption syndrome (> 60% of all cases), pernicious 
anemia (15%–20% of all cases), insufficient dietary intake and 
malabsorption. Helicobacter pylori has been implicated as the 
potential causative agent of vitamin B12 deficiency and pernicious 
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anemia. Gastritis caused by Helicobacter pylori leads to destruction of 
parietal cells Helicobacter pylori producing the intrinsic factor needed 
for vitamin B12 absorption.  It is well established that eradication of 
H. pylori led to improved blood levels of vitamin B12 in 40% of the 
cases.  
The aim of this study was to evaluate the association between vitamin 
B12 deficiency, and Helicobacter pylori infection. In addition we 
compared invasive and non invasive methods routinely used to 
diagnose Helicobacter pylori infection. Our finding indicates that 
Helicobacter pylori infection was detected in 71.66% of those patients 
tested. Vitamin B12 deficiency was evident in 72.1% of those cases. 
These result correlated well with elevated mean cell volume (MCV) 
62.8%. Smoking as well as gender does not seem to increase the risk 
of developing of vitamin B12 deficiency. 
Our results indicate that Helicobacter pylori is implicated as a 
causative agent in the development of adult vitamin B12 deficiency in 
adult. 
  
10  
 
 
Introduction 
Helicobacter pylori: 
Helicobacter pylori is one of humanity's oldest and closest 
companions, and yet it took scientists more than a century to 
recognize it. As early as 1875, German anatomists found spiral 
bacteria colonizing the mucus layer of the human stomach
 (1)
.  At that 
time the organism could not be grown in culture and this significant 
finding was overlooked for a long time. Over a century later, in 1982, 
two Australian physicians Barry J. Marshall and J. Robin Warren 
were able to isolate Helicobacter pylori from the stomach of patients 
and discovered its role in causing gastritis and peptic ulcers 
(2, 3)
. They 
have been awarded the Nobel Prize, (2005) in physiology and 
medicine for their pioneer work on this organism. In order to prove 
that this organism follows Robert Koch’s Postulate, Marshall went to 
the point of swallowing a culture of this organism. 
Helicobacter pylori is a fastidious Gram negative microorganism that 
has a spiral or helical shape. It has five to seven sheathed uni-polar 
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flagella. It requires high humidity, microaerophilic environment (5% 
O2 and 5 to10% CO2) and incubation temperature of 37
o
 C for growth. 
Although growth of Helicobacter pylori may appear after three to five 
days, the primary growth may take up to 7 days to appear
 (4)
. The 
colonial morphology is described as translucent, small pinpoint 
colonies
 (5)
. 
Helicobacter pylori is considered to be the most common human 
pathogen colonizing the gastric mucosa of almost all people 
(6)
Helicobacter pylori  causes chronic gastritis
 (7)
 and peptic ulcer 
disease
 (8)
. Helicobacter pylori has been classified as
 
a type I (definite) 
carcinogen since 1994. Helicobacter pylori  has been implicated in 
increasing the risk of developing gastric cancer which is the second 
most frequent cause of cancer-related
 
death 
(9,10)
.  Furthermore, 
Helicobacter pylori infection has also been considered to increase the 
risk of B-cell lymphoma of gastric mucosa-associated-lymphoid-
tissue (MALT –lymphoma) (21). It was shown that 72% to 98% of 
patients with gastric
 
MALT-lymphoma are infected with Helicobacter 
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pylori (
11)
 and treatment of Helicobacter pylori induced regression of 
MALT lymphoma in most cases 
(12)
. 
Epidemiology and Transmission: 
It is well accepted in the scientific community that infections with 
Helicobacter pylori occur worldwide. The prevalence of Helicobacter 
pylori varies depending on age, race, ethnicity, geographical location, 
household crowding and socioeconomic class
 (13)
 .Although more than 
50% of the world population carries Helicobacter pylori, the 
prevalence in the developing countries reaches a high proportion of 70 
to 90% 
(14)
. 
In developed countries such as Japan, the United States and Europe, 
the rate of infection was found to be below 20% in adolescents and 
increased slowly afterwards 
(15)
. It was also reported that 40% of 
infants and children of developing countries are already infected and 
the prevalence increases to reach 80% among adults 
(15)
. Many 
epidemiological studies on the prevalence of Helicobacter pylori 
among infants and children have been conducted in the developing 
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and developed countries. In Vietnamese children aged 0-4 years, the 
incidence of Helicobacter pylori infection was found to be 14%, as 
compared to 15% incidence among Egyptian children of similar age 
(16)
. 
The infection is believed to be acquired before 10 years of age
 (17)
. 
This is apparent in several developing countries where children have 
high rates of sero-positivity 
(18)
.  Although most studies reported an 
equal incidence rate between males and females, one study reported 
male sex to be a risk factor 
(19)
.  The socioeconomic conditions are 
strongly correlated to Helicobacter pylori infections 
(20)
. 
The mode of transmission of Helicobacter pylori remains 
undetermined until now. Theories support the notion that humans are 
the primary reservoir for Helicobacter pylori 
(21)
.  The person-to-
person mode of transmission is supported by the higher incidence of 
infection among institutionalized children and adults and the 
clustering of Helicobacter pylori infection within families 
(13)
.  Also 
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lending support to this concept is the detection of Helicobacter pylori 
DNA in vomitus, saliva, dental plaque, gastric juice, and feces. 
Waterborne transmission, probably due to fecal contamination, may 
be an important source of infection, especially in parts of the world in 
which untreated water is common 
(13)
. Studies have been also 
conducted on fresh and well water to determine the possibility to 
incriminate water as a source of transmission of this organism. One 
study concluded that Helicobacter pylori is waterborne and represent 
public hazard. In this study, it was suggested that Helicobacter pylori 
entered a morphological transition from rods to cocci. Although the 
bacteria was viable but non-culturable 
(22)
.  Another study used a 
selective medium (HP selective medium) supplemented with growth 
factors, polymyxin B, amphotericin B and phenol red indicator 
(23)
. 
Helicobacter pylori was isolated from well water on this selective 
medium within 7 days. Other reservoirs suggested include domestic 
cats 
(24)
 and houseflies
 (25)
. 
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Since Helicobacter pylori has been isolated from the feces of young 
children
 (26),
 or direct detection of stool antigens
 (27, 28)
, it is appropriate 
that transmission occurs via fecal-oral route within families during 
childhood
 (29, 30)
.  The oral-oral route of transmission was reported in 
African women who chew the food before feeding it to their children
 
(30)
. A possible route of transmission in developing countries is fecally 
contaminated water 
(31, 69)
.  It can also be transmitted from one person 
to another by vomit and saliva 
(32, 33)
. 
Helicobacter pylori Virulence: 
It is apparent that Helicobacter pylori have tropism to the gastric 
epithelial cells. It is the only bacterium that is adapted to colonize the 
hostile and highly acidic environment of the stomach (pH about 1-2). 
Upon entering the stomach, Helicobacter pylori can survive the 
deleterious effects of the gastric acid and dwell in the gastric mucus. 
This is achieved by the production of copious amounts of the urease 
enzyme. The urease enzyme (EC 3.5.1.5), is the most abundant 
protein in Helicobacter pylori constituting about 10% of the total 
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protein content of the cell. Urease raises the pH in the 
microenvironment surrounding the bacteria by hydrolyzing urea 
producing ammonia and carbon dioxide 
(34)
. The pathogenecity of 
Helicobacter pylori is definitely associated with the urease enzyme, 
since urease negative mutants fail to colonize mice
 (35,68 )
. 
 
The active urease enzyme consists of two structural subunits, UreA 
and UreB, six subunits each. Nickel ions are required as cofactor for 
the catalytic function of the enzyme 
(36)
.  In addition to the structural 
genes (ureA and ureB), the urease gene cluster carries ureI, ureE, ureF 
and ureH genes that must be co-expressed with the structural genes 
(36)
 
These additional genes are translated to proteins required for the 
synthesis of the catalytically active urease enzyme. The specific 
function of these accessory proteins is not well characterized except 
for ureI which can form a urea specific pore in the bacterial 
membrane. 
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The spiral shape of Helicobacter pylori and its uni-polar flagella are 
considered to be virulence factors that contribute to the pathogenecity 
of the organism. Both the spiral shape and the flagella cause a 
corkscrew-like motion enhancing the motility through the gastric 
mucus 
(37)
. Flagellar motility
 
is essential for colonization and protects 
the bacterial removal from the stomach by gastric peristalsis. Several 
researchers have studied the contribution of flagella and motility on 
the pathogenicity of Helicobacter pylori 
(38, 39)
. Motility is considered 
to be a virulence factor since non-motile mutants are either destroyed 
by the acidic environment of the stomach, or have great difficulty 
colonizing the gastric mucosa
 (38)
. Helicobacter pylori sheath is 
composed of a phospholipids bi-layer that functions specifically to 
protect the flagella from depolymerization in the acid environment of 
the stomach
 (40)
. Genetic analysis of Helicobacter pylori genome 
revealed the presence of about 40 proteins that control the secretion 
and assembly of the flagellar structure. The flagellar filaments consist 
of two protein subunits:  a major flagellin (FLaA), and a minor 
flagellin (FLaB). The intricate relationship of the structure, function 
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and assembly of the flagella and the genes controlling their activities 
is reviewed by Armelle et al
 (40)
. 
The lipopolysaccharide layer (LPS) of Helicobacter pylori is also 
considered to be a virulence factor contributing to the pathogenecity 
of the microorganism. Strains lacking the LPS layer (O, somatic 
antigen) loose their ability to colonize marine stomach 
(37)
. In addition 
to virulence, the LPS allow Helicobacter pylori to evade the immune 
system and colonize the host for a very long time 
(38)
. This is due to 
the fact that O antigen is composed of N-acetyl-D-glucosamine, L-
fucose , and D-galactose 
(41)
. These structures were proved to be 
identical to human blood group antigens Lewis X, Y, and b 
(37,67)
.  
Recent research had demonstrated for the first time a correlation 
between Helicobacter pylori internalization and lewis antigen 
expression by this organism 
(42)
. This significant finding was 
confirmed by testing Helicobacter pylori strains expressing Lewis 
antigens and strains with low level expression of the antigen. The 
strains expressing Lewis antigens were internalized at much greater 
levels than those with low level or non-expressing strains. 
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Helicobacter pylori live inside the mucus layer of the gastric mucosa. 
Studies have shown that Helicobacter pylori stimulate endothelial 
cells to upregulate adhesion molecule expression 
(43)
. Attachment to 
the gastric epithelial cells is mediated by outer membrane proteins 
(Hop proteins).  There are about 32 of these outer membrane proteins 
discovered. Several of these outer membrane proteins function as 
porin protein while others contribute to adhesion 
(44)
.  At least five 
different Helicobacter pylori adhesions are designated as BabA, 
SabA, AlpA, AlpB, and HopZ have been identified 
(45, 66, 70)
. BabA 
adhesion has been thoroughly investigated and well characterized. 
BabA adhesion is 78KD protein that mediates binding of Helicobacter 
pylori to the fucosylated Lewis b histo-blood group antigen present on 
the surface of gastric epithelial cells 
(46, 71)
. Studies on animal models 
revealed that Lewis b-dependent attachment of Helicobacter pylori to 
gastric epithelial cells are accompanied by increased severity of 
inflammation, development of parietal cell auto-antibodies, and 
parietal cell loss. 
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Helicobacter pylori infection is definitely the causative agent of 
gastritis and peptic ulcer disease 
(7, 8)
. In addition, it is involved in the 
development of gastric carcinoma and gastric mucosa-associated 
lymphoid tissue (MALT) lymphoma 
(10)
. Cure of this type of cancer 
by eradicating Helicobacter pylori has established the association 
between this organism’s virulence factors and MALT formation (47). 
Several Helicobacter pylori virulence associated genes that may play 
a role in its pathogenicity have been identified. The most important 
virulence associated genes are vacA and cagA. Clinical isolates of 
Helicobacter pylori have been classified as type I and type II strains 
depending on the presence or absence of these two genes. Type I 
strains carry both genes while Type II strains do not 
(48)
.  vacA gene is 
translated to produce a 95 KD protein known as vacuolating cytotoxin 
A (VacA)
 (49)
. VacA is an enterotoxin that induces vaculation in a 
wide variety of epithelial cells, cell death and destruction of epithelial 
integrity. Theories about the mechanism of action of VacA indicate 
that it is internalized by the gastric epithelial cells. Once inside the 
cell, VacA has two functions: one function is to form an anion 
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channel in the cell membrane where bicarbonate and other organic 
anions pass out of the cell and utilized by the bacteria. The other 
function is to cause damage to the mitochondria releasing cytochrome 
C and initiating apoptosis 
(49)
. vacA gene contributes significantly to 
the diversity of Helicobacter pylori  strains. vacA is considered to be 
a mosaic gene containing both conserved as well as diverse regions
(50)
. 
Within the diverse region two regions have been identified: the 
mosaic combination of signal region, (s-region) and the middle region 
(m-region)
 (51)
. In the s-region, there are three s type alleles referred to 
as s1a, s1b and s2 and two m type alleles, m1 and m2 in the m-region
 
(50, 51)
. Genotypes containing s1a are always associated with severe 
inflammation while m1 strains are associated with severe epithelial 
injury 
(52)
. 
Another major virulence factor of Helicobacter pylori is the cag 
pathogenicity island (PAI). PAI constitutes a 37-kb fragment on the 
DNA and contains 29 genes
 (49)
. Several of these genes encode a type 
IV secretion system (T4SS) which is responsible for transporting the 
translated cagA protein inside the host gastric epithelial cells. CagA 
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protein is 120-kD that becomes phosphorylated by the action of a 
tyrosine kinase inside the host cell, inducing it to produce cytokines. It 
is commonly found in patients with severe gastro- duodenal diseases, 
including peptic ulcers and gastric adenocarcinomas 
(53)
. 
Studies have revealed an area of Helicobacter pylori chromosome that 
is distinct from the cag Pathogenicity Island (PAI) and with different 
G+C content. This was referred to as the plasticity region. Recent 
research revealed the existence of JHP940 and JHP947 genes. Both 
genes were detected in Helicobacter pylori strains from patients with 
gastric cancer. JHP947 on the other hand, was more frequently 
detected (64.7%) in strains from patients with gastric cancer 
(54)
. 
 
Gastroduodenal Pathology and Immunity: 
Helicobacter pylori causes active chronic gastritis
 (7)
, peptic ulcer 
disease
 (8)
, gastric cancer and increase the risk for developing B-cell 
lymphoma of gastric mucosa-associated-lymphoid-tissue (MALT –
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lymphoma)
 (11)
.  The pathogenesis of Helicobacter pylori -associated 
gastrointestinal disease remains poorly understood.  Available 
information confirms that Helicobacter pylori infections never resolve 
spontaneously. The chronic gastritis usually contributes to the 
development of peptic ulcer disease and gastric cancer. Known 
virulence factors of this organism can either determine the course of 
the disease, colonization of gastric mucosa or the pathogenesis of the 
disease. 
After infection, Helicobacter pylori causes acute gastritis 
accompanied by epithelial degeneration of the apical mucosa and 
localized erosion. Acute gastritis is characterized with infiltration of 
neutrophiles into the lamina propria underlying the mucosal surface. 
Acute phase is replaced by a chronic phase which is characterized by 
persistent infiltration to the lmina propria of neutrophiles 
accompanied by infiltration of mononuclear cells mainly lymphocytes 
and plasma cells 
(55)
. The function of neutrophiles is to engulf the 
bacteria and destroy it by oxygen burst creating highly reactive 
radicals such as hydrogen peroxide, superoxide anions and hydroxyl 
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radicals. Helicobacter pylori can defend it self against these 
deleterious effects. It has the enzymes catalase and superoxide 
dismutase. The catalase enzyme degrades the hydrogen peroxide into 
water and oxygen while the superoxide dismutase catalyzes the 
superoxide anions to hydrogen peroxide and oxygen. In addition, 
Helicobacter pylori colonize the mucus layers of the gastric 
epithelium. This area is out of reach of the neutrophiles. When the 
neutrophiles reach this area they become exposed to the gastric acid, 
lyse and their reactive molecules cause damage to the gastric 
epithelium. 
Exposure of Helicobacter pylori to the immune system is minimal. 
The inflammatory response to the presence of this organism is not 
capable of eliminating it. Helicobacter pylori cause three different 
types of immune reactions acute, chronic active, and the atrophic 
stages of gastritis. These are all stages of inflammation caused by the 
immune system. The infected mucosal cells secrete interleukin-8 (IL-
8), a neutrophile activating chemokine that actually initiates the 
inflammatory cascade and eventually results in the development of 
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chronic active gastritis. Helicobacter pylori strains carrying the vacA 
pathogenicity island tend to secrete factors that increase the 
production of IL-8, leukotrienes and complement factors which 
represent the chemo attractants for the neutrophiles and lymphocytes. 
As the pH in the stomach returns to normal (pH=2), the chronic active 
gastric phase begins. During this stage, the immune system cells will 
encounter Helicobacter pylori antigens and mount an immune 
response releasing IgG and IgA antibodies. The immune response can 
not eliminate the bacterium, but amplify damage to gastric epithelial 
cells. This stage may last for many years and results in development 
of ulcers in most patients. 
Chronic infections with Helicobacter pylori results in the 
development of multifocal atrophic gastritis. There is a loss of gastric 
glands, transmural inflammation, and intestinal metaplasia. The 
presence of the intestinal metaplasia is of great significance because it 
is considered as the first step in malignant transformation 
(56)
. 
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Studies on experimental animals show a strong relationship between 
the presence of Helicobacter pylori and the development of gastric 
cancer. There are two possible theories on how Helicobacter pylori 
cause cancer. Cancer is either a result of years of inflammation 
causing damage and regeneration of the gastric epithelial cells or a 
result of an increased pH in the stomach allowing bacteria that 
produce reactive nitrogen compounds, to colonize the stomach. These 
bacteria could produce cancer-causing compounds that induce 
mutations in the gastric epithelium
 (57)
. 
Helicobacter pylori is capable of antigenically stimulating the 
immune system leading to MALT lymphoma. These types of cancer 
develop from the continual activation of T lymphocytes to increase 
the proliferation of B-lymphocytes. Evidence shows that MALT 
lymphomas of the B-cell type, contain many tumor infiltrating T-cells 
that are antigenically stimulated by Helicobacter pylori. These T-cells 
stimulate the growth of the low-grade MALT lymphoma 
(57)
. 
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Removing the Helicobacter pylori antigenic stimulus causes the 
lymphoma to degenerate. This is some of the most important evidence 
in the relationship between Helicobacter pylori and malignant tumors. 
 
 
 
 
 
 
 
Vitamin B12 (cobalamin) Deficiency and Pernicious Anemia: 
Vitamin B12 is a large molecule composed of a heme-like compound 
kmown as corrin that holds an atom of cobalt. The corrin and the 
cobalt atom make up the cobalamin portion of vitamin B12. Several 
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cobalamines exist and are identified according to their attachments. 
Methylcobalamin for example, is a cobalamin with a methyl group 
attached. There are two active forms of cobalamins in the human 
body: adenosylcobalamin and methylcobalamin. Other cobalamines 
commonly found in food and supplements such as cyanocobalamin 
and hydroxycobalamin. These forms can be converted inside the 
human body into one of the two active forms. 
Vitamin B12 (cobalamin) is an important water-soluble vitamin. In 
contrast to other water-soluble vitamins it is not excreted quickly in 
the urine, but rather accumulates and is stored in the liver, kidney and 
other body tissues. As a result, a vitamin B12 deficiency may not 
manifest itself until after 5 or 6 years of a diet supplying inadequate 
amounts 
(41)
. Vitamin B12 functions as a methyl donor and works with 
folic acid in the synthesis of DNA and red blood cells and is vitally 
important in maintaining the health of the insulation sheath (myelin 
sheath) that surrounds nerve cells 
(73)
. The classical vitamin B12 
deficiency disease is pernicious anemia, a serious disease 
characterized by large, immature red blood cells. It is now clear 
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though, that a vitamin B12 deficiency can have serious consequences 
long before anemia is evident. The reference levels in blood of 
vitamin B12 ranges between 200 and 600 picogram/milliliter (148-443 
picomol/liter)
 (74)
.  
A deficiency often manifests itself first in the development of 
neurological dysfunction that is almost indistinguishable from senile 
dementia and Alzheimer's disease. There is little question that many 
patients exhibiting symptoms of Alzheimer's actually suffer from a 
vitamin B12 deficiency. Their symptoms are totally reversible through 
effective supplementation. A low level of vitamin B12 has also been 
associated with asthma, depression, AIDS, multiple sclerosis, tinnitus, 
diabetic neuropathy and low sperm counts. Clearly, it is very 
important to maintain adequate body stores of this crucial vitamin 
(74)
.  
The amount of vitamin B12 actually needed by the body is very small, 
probably only about 2 micrograms or 2 millionth of a gram/day. 
Unfortunately, vitamin B12 is not absorbed very well so much larger 
amounts need to be supplied through the diet or supplementation. The 
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richest dietary sources of vitamin B12 are liver, especially lamb's 
liver, and kidneys. Eggs, cheese and some species of fish also supply 
small amounts, but vegetables and fruits are very poor sources. 
Several surveys have shown that most strict, long-term vegetarians are 
vitamin B12 deficient. Many elderly people are also deficient because 
their production of the intrinsic factor needed to absorb the vitamin 
from the small intestine decline rapidly with age 
(74)
.  
Fortunately, oral supplementation with vitamin B12 is safe, efficient 
and inexpensive. Most multi-vitamin pills contain 100-200 microgram 
of the cyanocobalamin form of B-12
(74)
. This must be converted to 
methylcobalamin or adenosylcobalamin before it can be used by the 
body. The actual absorption of B12 is also a problem with 
supplements 
(74)
. Swallowing 500 micrograms of cyanocobalamin can 
result in absorption of as little as 1.8 microgram so most 
multivitamins do not provide an adequate daily intake. The best 
approach is to dissolve a sublingual tablet of methylcobalamin (1000 
micrograms) under the tongue every day. That will be sufficient to 
maintain adequate body stores. However, if a deficiency is actually 
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present then 2000 microgram/day for one month is recommended 
followed by 1000 microgram/day. Some physicians still maintain that 
monthly injections of vitamin B12 is required to maintain adequate 
levels in the elderly and in patients with a diagnosed deficiency. There 
is however, no scientific evidence supporting the notion that injections 
are more effective than sublingual supplementation
 (74)
.  
Helicobacter pylori has been implicated as the causative agent of 
vitamin B12 deficiency and pernicious anemia 
(48)
. Helicobacter 
pylori is a common cause of gastritis and ulcers and it destroys the 
parietal cells that produce the intrinsic factor needed for vitamin B12 
absorption.  Successful eradication of Helicobacter pylori led to 
improved blood levels of B12 in 40% of those infected
 (48)
. 
Helicobacter pylori was found in 56% of patients with pernicious 
anemia
 (63)
. It was also found that Helicobacter pylori -induced 
vitamin B12 deficiency occurs in the absence of atrophic gastric 
mucosa
 (48)
.  
 Pernicious Anemia 
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 Pernicious anemia (PA) is the most common cause of vitamin B12 
deficiency. B12 deficiency actually has many causes however 
pernicious anemia applies only to the condition associated with 
chronic atrophic gastritis 
(74)
.  
 Pernicious anemia was first described by Addison in 1849 and 
associated with the stomach by Austin Flint in 1860. Pernicious 
anemia was later successfully treated with cooked liver and 
subsequent theories on the pathogenesis of Pernicious anemia 
involved the loss of an extrinsic factor from the liver and an intrinsic 
factor (IF) from the stomach 
(74)
.  
 A recent population survey found that approximately 2% of persons 
over 60 years of age have undiagnosed Pernicious anemia. The 
disease was previously thought to occur only in those of Northern 
European extraction; however subsequent studies have noted 
Pernicious anemia to occur in Hispanic and African-American 
patients
 (74)
.  
Pathology  
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   Gross pathology – The stomach has three regions: the fundus and 
the body, which contain acid secreting parietal cells and pepsinogen 
secreting zymogen cells, and the antrum which contain gastrin 
secreting G-cells. Chronic atrophic gastritis is recognized grossly by 
the loss of gastric mucosal folds and thinning of the gastric mucosa. 
 
 
 
  There are two types based on whether the lesion affects the 
antrum
(58)
.  
Type A (autoimmune) Chronic Gastritis Type B (nonautoimmune) Chronic 
Gastritis 
Affects fundus and body, spares antrum Affects antrum as well as fundus and body 
Associated with PA, antibodies vs. IF, 
parietal cells 
No autoimmunity, Helicobacter pylori 
infection common 
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Hypergastrinemia secondary G-cell 
hyperplasia and low serum pepsinogen-I 
Hypogastrinemia secondary G-cell 
destruction with antral gastritis 
Achlorohydria, gastric carcinoids   
 
 Histopathology – Gastric biopsy specimens from patients with early 
Pernicious anemia demonstrate a mononuclear cellular infiltrate in the 
submucosa extending into the lamina propria between the gastric 
glands; the infiltrate consists of plasma cells containing autoantibodies 
to parietal cells and intrinsic factor. Extension of the cellular infiltrate 
into the mucosa is accompanied by degenerative changes in parietal 
and zymogenic cells. In the fully established lesion, there is marked 
reduction in the number of gastric glands and the parietal and 
zymogenic cells disappear, and replaced with mucus containing cells 
which resemble intestinal cells (intestinal metaplasia)
 (74)
. 
 Natural History – The progression of Type A chronic atrophic 
gastritis to gastric atrophy and anemia is estimated to be 20-30 years. 
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The presence of parietal cell antibodies is predictive of the presence of 
autoimmune gastritis, being found in 90% of patients with Pernicious 
anemia (50% of those with gastric atrophy without Pernicious 
anemia); anti-intrinsic factor antibodies are found in 60% of 
Pernicious anemia patients, anti-parietal cell antibodies are found in 
10-15% of the general population whereas anti-Intrinsic factor 
antibodies are typically seen only in those with Pernicious anemia 
(46)
.  
 Immunopathogenesis – The pathologic process of type A gastritis 
appears to be directed against the gastric parietal cell. The pathology 
is restricted to the parietal cell containing gastric fundus and body, 
parietal cells are lost, and autoantibodies against parietal cells and 
their product, IF, are present in the serum and gastric juice. It was 
recently determined that antigen for the anti-parietal antibodies is the 
gastric H
+
/K
+
-ATPase. Although these antibodies fix complement and 
lyse parietal cells in vitro, it is unlikely that they are pathogenic in 
vivo as the H
+
/K
+
-ATPase is not accessible to circulating antibodies. 
Murine studies suggest that the lesion of autoimmune gastritis is 
initiated by CD4 cells that recognize the b subunit of gastric H
+
/K
+
-
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ATPase. However the mechanism of activation of the CD4 cells is not 
known, nor is the pathway by which these cells produce chronic 
gastritis 
(74)
.  
 Genetics – A genetic predisposition to Pernicious anemia is 
suggested by the clustering of the disease and of gastric antibodies in 
families and the autoimmune endocrinopathies. About 20% of 
relatives of patients with Pernicious anemia have Pernicious anemia 
themselves. However there is no evidence of an association of 
Pernicious anemia with certain Human Leukocytes Antigen (HLA) 
molecules
 (74)
.   
Associated diseases – Pernicious anemia may be associated with 
many other autoimmune endocrinopathies, including Hashimoto’s 
thyroiditis, Addison’s disease, primary gonadal failure, primary 
hypoparathyroidism, Graves’ disease, vitiligo, myasthenia gravis, and 
the Eaton-Lambert syndrome 
(74)
. 
Vitamin B12 absorption, malabsorption, and metabolism:  
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 B12 is a complex molecule that cannot be synthesized in the human 
body and must be supplied in the diet (MDR=2.5mg) from meat and 
dairy foods primarily. During gastric digestion B12 is released from 
food and complexes with gastric R binder; in the duodenum the B12-R 
binder complex is digested and the B12 then binds to intrinsic factor 
(IF). The B12-Intristic factor complex then travels to the distal ileum 
where specific receptors bind and absorb the complex. In the mucosal 
cell the IF is degraded and the B12 associates with another transport 
protein, transcobalamin II (TC II) which is secreted into the 
circulation where it is rapidly taken up by the liver, bone marrow, and 
other cells.
 (42)
.  B12 malabsorption in PA is due to lack of IF due to 
loss of gastric parietal cell as well blocking antibodies present in the 
gastric that can bind and block the B12 binding site on IF
(42)
. Normally 
2mg of B12 is stored in the liver and 2mg elsewhere in the body, in 
view of the MDR it would take 3-6 years to become B12 deficient if 
absorption were to cease 
(42)
. B12 is metabolically active in 2 forms – 
methylcobalamin which is an essential cofactor in the conversion of 
homocysteine to methionine and adenosylcobalamin which is required 
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for the conversion on methylmalonyl CoA to succinyl CoA. Therefore 
with B12 deficiency one would expect to see elevated serum levels of 
homocysteine and methylmalonic acid 
(42)
. 
Picture(1) show the mechanism of vitamin B12 absorption
(42)
. 
Clinical Presentations  
 Anemia with symptoms that include fatigue, weakness, light-
headedness, vertigo, tinnitus, palpitations, angina, decreased exercise 
capacity with pallor, slight icterus, tachycardia, and systolic flow 
murmur on exam.  
 Gastrointestinal complications of B12 deficiency include atrophic 
glossitis with a smooth beefy red tongue and megaloblastosis of the 
small bowel with diarrhea and malabsorption. In the stomach 
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intestinal metaplasia is a risk factor for adenocarcinoma – population 
based studies demonstrated that the risk of gastric adenocarcinoma 
was increased three times and the risk of gastric carcinoid (felt to be 
due to the trophic effects of gastrin) was increased 13 times in patients 
with Pernicious anemia and one study recommended endoscope 
surveillance of patients with Pernicious anemia.  
 Neurologic complications include peripheral neuropathy, most 
frequently seen as numbness and paresthesias, lesions of the dorsal 
columns (with loss of vibration and position sense and ataxia) and 
lateral columns (with limb weakness, spasticity, and extensor plantar 
reflexes) of the spinal cord (subacute combined degeneration) and 
cerebrum (with changes ranging from mild personality defects and 
memory loss to frank psychosis (megaloblastic madness)). These 
lesions begin as demyelination and progress to axonal degeneration 
and eventually neuronal death; these complications may not be 
reversed by treatment. 
Laboratory Diagnosis  
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 The finding of macrocytosis suggests the presence of a megaloblastic 
anemia; an MCV <95fL implies a less than 0.1% chance of B12 (or 
folate) deficiency; an MCV of 100-110fL is most likely due to 
ethanol, stem cell disorders, liver disease, or the use of 
antineoplastics; as the MCV rises so does the chance of B12 or folate 
deficiency (MCV>130fL is associated with B12 or folate deficiency in 
nearly 100%).  
 The peripheral blood smear may also show hypersegmented 
neutrophils (about 91% sensitive, defined as the presence of at least 
neutrophil with 6 lobes, the presence of ³ 5% of 5-lobe neutrophils, or 
an increased neutrophil lobe average (normally <3.4lobes/PMN), 
RBCs, in addition to macrocytosis, demonstrate anisocytosis and 
poikilocytosis, decreased reticulocyte count as well as possible 
leukopenia and thrombocytopenia.  
 Megaloblastic anemias are characterized by ineffective erythropoiesis 
with enhanced intramedullary destruction of erythroblasts as 
evidenced an increase in indirect bilirubin and LDH1.  
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 Once a megaloblastic anemia has been identified, one should then 
determine whether a specific vitamin deficiency is responsible by 
measuring serum cobalamin (Cbl) and folate levels. However there 
has been some recent controversy regarding Cbl levels, with some 
feeling that the true lower limit of normal for B12 should be 300pg/mL 
(and not 193 as at UNCH).  
 There are several other tests for diagnosing Cbl deficiency and PA. 
These include serum methylmalonic acid (MMA) and homocysteine 
(Hcy) levels, both of which should be elevated in B12 deficiency 
whereas only Hcy should be increased in folate deficiency; a recent 
study found that elevations of both MMA and Hcy had a 98% 
sensitivity for B12 deficiency. Additional tests include serum 
transcobalamin II, which delivers B12 to cells and whose concentration 
falls before that of B12, the deoxyuridine suppression test (dUST) 
which measures thymidine incorporation into DNA by marrow cells 
and their response on addition of Cbl and folate (not widely used due 
to need for bone marrow biopsy), MMA 24 hour urinary excretion, IF 
and parietal cell antibodies, type A chronic atrophic gastritis on 
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gastric biopsy, achlorohydria (very sensitive as Pernicious anemia is 
the only gastric lesion that results in total achlorohydria); One may 
also obtain serum gastrin and pepsinogen levels, which are increased 
and decreased respectively. Once B12 deficiency has been established, 
its pathogenesis can be established by means of a Schilling test. The 
classic test is conducted by first giving the patient 1000 m g of cold 
B12 intramuscularly then giving 1 mg of 
57
Co-cyanocobalamin orally; 
a 24 hour urine is then obtained with normal subjects excreting more 
than 8% of the oral dose; subsequent steps entail the administration of 
the labeled B12 with IF (which should normalize the urinary excretion 
in Pernicious anemia patients), pancreatic extract for patients with 
suspected pancreatic insufficiency, and following antibiotic 
administration for those with suspected bacterial overgrowth. In 
patients with suspected Pernicious anemia usually only steps one and 
two are performed
 (74)
. 
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Helicobacter pylori and vitamin B12 deficiency 
A Turkish study showed a patient population consisted of 102 men 
and 208 women with a mean age of 43 ± 12 (range16 to 75 ) years. 
The mean serum vitamin B12 concentration for 310 patients was 216 
pg/mL. The percentages of patients with concentrations < 250 pg/mL, 
< 200 pg/mL and ≤100 pg/mL were 67.4%, 46.8%, and 6.5% 
respectively. Patients with <200 pg/mL of serum vitamin B12 
concentration were older than those with >200 pg/mL (p<0.01). Sex 
and other hematology parameters of patients with or without vitamin 
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B12 deficiency did not show any significant difference by univariate 
analysis 
(48)
. 
Other study showed that patients with good oral hygiene had less 
gastric recurrence of Helicobacter pylori after treatment, and 
eradication of the organism increased serum vitamin B12
 (49)
. Other 
research has given further support to a suggested link between 
Helicobacter pylori infection and vitamin B12 deficiency 
(43)
. 
Investigators previously found that both pernicious anemia and food-
cobalamin malabsorption the most common causes of vitamin B12 
deficiency, especially in older people - were associated with chronic 
gastritis and might be associated with Helicobacter pylori infection
 
(43)
. To test this in more detail, gastroenterologists prospectively 
studied 138 patients with macrocytic anemia and vitamin B12 
deficiency that did not have a classic cause, such as pernicious anemia 
or postgastrectomy state, and who had Helicobacter pylori confirmed 
by gastric biopsies 
(50)
.  
Helicobacter pylori infection was eradicated with a triple-therapy 
regimen and eradication was confirmed by further gastric biopsies 
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after four weeks. All patients were followed up at three-month 
intervals for up to five years
 (50)
.None of the patients infected with H 
pylori received vitamin B12 replacement unless the Helicobacter 
pylori could not be eradicated
 (50)
.  
A total of 77 (55.8 %) patients were infected with H pylori. 
Eradication was successful in only 31 cases (40.3%). In all patients 
with H pylori, serum vitamin B12 levels, macrocytosis and anaemia 
were normal within six months of the infection being vanquished
 (50) 
Although multi-stage Schilling and auto-antibody tests were not 
performed, and the histological findings of the gastric biopsy were not 
reported, the findings did support a relationship between H pylori 
infection and vitamin B12 deficiency, the authors concluded
 (50)
. 
They suggested that eradicating Helicobacter pylori infection might 
correct vitamin B12 levels and improve anemia by reversing gastric 
atrophy related to the infection
 (50)
. Helicobacter pylori In a new study, 
34 individuals with dysmotility-like dyspepsia, Helicobacter pylori 
infection, and low vitamin B12 levels were assessed before and after a 
three-month course of vitamin B12 therapy. Each person received 
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daily intramuscular injection of vitamin B12 (1,000mcg) for 10 days, 
followed by 1,000 mcg per day orally for 80 days. The rate of gastric 
emptying and the severity of symptoms were determined before and at 
the end of treatment period. The average time required to empty the 
stomach contents decreased from 230 minutes at the start of the study 
to 98 minutes after vitamin B12 therapy. In addition, the severity of 
the intestinal symptoms improved by an average of 78%. These 
results suggest that correction of vitamin B12 deficiency can improve 
delay gastric empting and relieve symptoms in this particular subset of 
individuals with dyspepsia
 (51).
Another new study on 133 adults how 
have a history of Helicobacter pylori  infection, tested for complete 
blood count ,vitamin B12 level, gastrin, folic acid, and h.pylori IgG 
antibodies, the study show that 51% of subjects seropositive  to 
Helicobacter pylori  had vitamin B12 >250 pg/ml which indicated a 
relationship between Helicobacter pylori  infection and vitamin B12 
level
 (51). 
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Hypothesis and specific aims 
Hypothesis: 
We hypothesize that Helicobacter pylori  is implicated as a causative 
agent for vitamin B12 deficiency by causing stomach ulcer and 
destroys the parietal cells which impair vitamin B12 absorption 
regardless of age. 
Specific aims: 
Our specific aims in this study are the following: 
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To investigate the existence of a possible association between 
Helicobacter pylori infection and vitamin B12 deficiency. 
To evaluate and compare invasive and non-invasive methods used for 
detecting Helicobacter pylori infection. The outcome of such 
evaluation may establish a correlation between the reference invasive 
method (Gastric biopsy) and other non-invasive methods. Such 
correlation may be used to adopt those non-invasive techniques in 
diagnosing Helicobacter pylori infection. 
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Materials and Methods 
This study was done on 60 adult patients (32 males, 28 females) 
selected for this study from 86 patients, 26 patients were excluded 
from this studies ( 12 patient have renal or liver disease, 14 patient 
received Helicobacter pylori eradication therapy), the duration of the 
study was between november/2003 and november/2004. All patients 
had symptoms of NUD (Non Ulcer Dyspepsia) or GERD 
(Gastroesophageal Reflux Disease).Gastroscopy was performed in the 
endoscopy unit of Arabcare Hospital in Rammallah by Dr. Wail 
Hammoudeh, FACP. Three to four antral gastric mucosa biopsies 
were collected by endoscopy. If the patient had previous treatment 
with PPI (Proton Pump Inhibitor), another biopsy was taken from the 
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corpus. Distal esophageal mucosa biopsies were taken when 
observing an esophageal abnormality, the Esophageal Gatro-duodenal 
finding were documented. One biopsy was examined immediately by 
rapid urease test (CLO test) for Helicobacter pylori infection and 
other for histolopathology. Prior to gastroscopy blood sample were 
obtained, and patient information was collected regarding age, sex, 
duration, of symptoms, previous treatment with PPI (yes or no) and 
smoke ( yes or no). The blood sample was aseptically collected from 
each patient in an EDTA and plain vacutainer tubes for Complete 
Blood Count (CBC) to determine the MCV and for vitamin B12 
assay.  Complete Blood Count was performed using Sysmex analyzer 
(automated counter, Sysmex-Japan) to obtain the MCV for each 
specimen and vitamin B12 was measured using an Immulite analyzer 
(DPX, USA). 
Selection criteria for enrollment in the study were: 
Patients enrolled in this study were selected according to the 
following criteria: 
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The patients do not have any classic cause of cobalamin deficiency, 
such as pernicious anemia or the postgastrectomy state. And had no 
evidence of renal failure or liver disease. Female patients were not 
pregnant. The patients had not received previous Helicobacter pylori 
eradication therapy. 
Patients were interviewed to role out the existence of medical problem 
that may affect cobalamin status and to determine that they had 
received cyanocobalamin treatment parenteral. 
Rapid Urease Test (CLO-Test)  
The CLO-Test (manufacture by Biomerux Company) is a qualitative 
test for the detection of the unease enzyme produced by H. pylori. If 
Helicobacter pylori is present in the sample, unease will hydrolyze the 
urea causing the formation of positive ammonium ions.   This causes a 
rise in pH which is detected by the phenol red indicator that changes 
color from yellow to red/magenta. A solution of 10% urea broth 
containing 0.1% phenol red is used as outlined by Eugina 
(46)
. 
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The biopsy specimens of each patient were examined by this rapid 
urease test by placing a biopsy in the broth.  The development of a red 
color within 2 hours indicated a positive result.  
 
 
Impression biopsy slides 
One biopsy was firmly pressed on several places on a clean sterilized 
microscope slide. The slide was air-dried and stained by gram stain. 
The presence of Gram negative spiral shaped bacteria indicating the 
presence of Helicobacter pylori. 
Histopathology  
Biopsies (several pieces 2-4) were placed in 10% buffered-formalin 
and sent to the pathology department at Medicare laboratories in 
Nablus. The biopsies were dehydrated and then embedded in paraffin. 
Sections were cut at 5um thick and stained with hematoxylin and 
eosin. Examination for the presence of Helicobacter pylori was made 
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by the Pathologist Dr.Husni Magbool (Medicare Nablus). The 
presence of Helicobacter pylori can be seen colonizing the gastric 
mucosa, indicating positive histopathology test for Helicobacter 
pylori. 
 
Serological testing 
Poly Stat Helicobacter pylori test kit (Polymedco Inc. USA) was used 
for the qualitative detection of anti-Helicobacter pylori IgG in human 
serum was used. This is a chromatographic immunoassay. The test 
cartridge contains a membrane coated with H. pylori antigens 
conjugated with colloidal gold on the test band and Helicobacter 
pylori specific monoclonal antibody on the control band. The 
formation of a visible line in the test region indicates the presence of 
IgG antibodies specific for Helicobacter pylori. Another band will 
always appear in the control region. The appearance of the control 
band indicates that enough samples have been added and proper flow 
is obtained.  
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Vitamin B12 Assay  
Vitamin B12 (cobalamin) was assayed using a solid-phase 
chemiluminescent competitive binding assay (Immulite, DPC, USA). 
Specimens to be assayed (serum or plasma), were heated for 15 
minutes in a water bath at 100
o
 C in the presence of dithioereitol and 
potassium cyanide. This pretreatment was used to release vitamin B12 
from its binding proteins. Mix of 100 ul of the pretreated sample in a 
reaction vessel with hog intrinsic factor (HIF) and an anti-HIF 
monoclonal antibody. This anti-HIF monoclonal antibody was labeled 
with alkaline-phosphatase. An aliquot of this mixture was introduced 
into a reaction tube containing vitamin B12-coated beads. The 
chemiluminescent substrate was then added and undergoes hydrolysis 
in the presence of the enzyme label. This reaction yields a result that 
relates inversely to the vitamin B12 concentration in the patient 
sample. The anti-HIF MAb used in this assay was specifically 
produced and selected to bind HIF without interfering with the latter’s 
ability to bind vitamin B12. Unbound materials are removed by a 
patented centrifugal wash technique. The chemiluminescent substrate, 
  
55  
 
 
a phosphate ester of adamantyl dioxetane, yields an unstable 
intermediate in the presence of the alkaline phosphatase label. This 
intermediate is continuously produced, resulting in a sustained 
emission of photons, and allowing multiple readings for enhanced 
precision by IMMULITE analyzer. 
Results  
This study was conducted between November 2003 and November 
2004. There were 60 patients (29 females and 31 males) randomly 
selected from patients with symptoms suggestive of Helicobacter 
pylori infection. Several tests were performed on the specimens 
collected from these patients. These tests included CBC, vitamin B12, 
CLO, pathology and serology. A summary of all the patients, 
symptoms, age, smoking status as well as the laboratory and 
pathology test results obtained for each specimen is outlined in Table 
(1).The age distribution of the patients was between 20 and 82 years 
as shown in Figure 1. The mean age was 44.1 + 17.5 years.  Most of 
the patients tested were 20 to 40 years old. With respect to age, we 
  
56  
 
 
divided the population into three age groups, group 1 (20 – 40 years 
old), group 2 (41-60 years old) and group 3 (> 61 years old). Our 
results indicated that Helicobacter pylori was present in 56% in age 
group 1, 19% in age group 2 and 26% in age group 3. The results are 
shown in Table 2 and depicted in Figure 1. 
Table 1. Summary of all patients and results obtained. Demographic information 
with respect to age and gender as well as smoking is shown. Other information 
shown, include symptoms, serology results, CLO test results, MCV and vitamin 
B12 levels. 
PATIENT 
NO. 
AGE SEX SMOKING RAPIDSIGNAL 
TEST 
CLO 
TEST 
PATHOLOGY 
RESULT(PRESENCE 
OF H.PYLORI} 
PATHOLOGY 
REPORT 
MCV VITAMINB12 
LEVEL 
1 65 f no positive positive positive Chronic sup.gadtritis 93 146 
2 75 f no negative negative negative Esophageal 
Adenocarcinoma 
85 242 
3 32 m Heavy 
smoker 
positive positive positive Sever gastritis 97 206 
4 82 m no positive positive positive Chronic gastritis 103 174 
5 73 f no positive positive positive Chronic gastritis 98 172 
6 68 m s positive positive positive  Sup.Gastritis  88 493 
7 20 m no positive positive positive Mild esophegitis 
chronic anturm 
gastritis 
83 340 
8 61 m no positive positive positive Mild esophegitis 
chronic gastritis 
107 103 
9 26 m s positive positive positive Mild esophegitis 
chronic gastritis 
83 422 
10 35 f no positive positive positive Epithelial 
hyperplasia chronic 
gastritis 
108 >100 
11 24 m no positive positive positive Mild esophegitis 
chronic gastritis 
92 242 
12 41 m s positive positive positive Esophageal 
hyperplasia chronic 
gastritis 
89 116 
13 57 m s positive positive positive Esophageal 
ulceration 
103 >100 
14 37 f no negative negative negative Epithelial 
hyperplasia  mild 
chronic gastritis 
79 342 
15 36 m s positive positive positive Epithelial 
hyperplasia chronic 
gastritis 
105 162 
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16 58 f no positive positive positive Epithelial 
hyperplasia  active 
chronic gastritis 
98 139 
17 34 m s positive positive positive Epithelial 
hyperplasia chronic 
gastritis 
89 249 
18 27 f no positive positive positive Moderate gastritis 78 802 
19 33 m no positive positive positive Epithelial 
hyperplasia chronic 
gastritis 
88 109 
20 49 f no negative negative negative Non –hodgkins 
lymphoma 
83 321 
21 32 m s negative negative negative Mild gastritis 85 378 
22 27 m s negative negative negative Chronic gastritis 80 380 
23 24 f no negative negative negative  Mild gastritis 78 447 
24 57 f no negative negative negative Mild gastritis 83 328 
25 38 m s positive positive positive Epithelial 
hyperplasia chronic 
gastritis 
89 177 
26 38 f no positive positive positive  Active gastritis 93 135 
27 33 m s negative negative negative Esophageal 
hyperplasia chronic 
gastritis 
78 791 
28 80 m no negative negative negative adenocarcinoma 73 1185 
29 80 f no positive positive positive Esophageal 
hyperplasia chronic 
gastritis 
101 127 
30 26 m no positive positive positive Esophageal peptic 
ulceration 
99 >100 
31 30 m no negative negative negative Mild gastritis 75 375 
32 32 f no positive positive positive chronic gastritis 93 120 
33 81 m s positive positive positive Active peptic ulcer 96 120 
34 61 f no positive positive positive  Mild Epithelial 
hyperplasia chronic 
gastritis 
91 173 
35 56 m s negative negative negative Mild gastritis 78 664 
36 32 m s positive positive positive Mild Epithelial 
hyperplasia chronic 
gastritis 
102 138 
37 38 f no positive positive positive Severe active 
chronic gastritis 
93 299 
38 32 m s positive positive positive Severe active 
chronic gastritis 
83 1103 
39 28 f no negative negative negative Severe active 
chronic gastritis 
80 451 
40 42 f no positive positive positive Severe active 
chronic gastritis 
99 126 
41 28 f no negative negative negative Mild chronic 
gastritis 
76 465 
42 28 f no negative negative negative normal 81 401 
43 48 m no positive positive positive Severe chronic 
gastritis 
98 164 
44 45 f no positive positive positive Severe active 
chronic gastritis 
100 161 
45 62 f no positive positive positive Severe active 
chronic gastritis 
101 136 
46 38 m no positive positive positive Severe active 
chronic gastritis 
96 155 
47 38 f no positive positive positive Severe active 
chronic gastritis 
99 178 
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48 71 f no positive positive positive Acute ulceration 
Severe chronic 
gastritis 
89 377 
49 60 f no positive positive positive Severe active 
chronic gastritis 
88 362 
50 42 m no positive positive positive Severe active 
chronic gastritis 
98 162 
51 30 m no positive positive positive Severe active 
chronic gastritis 
81 >1200 
52 52 m s negative negative negative Mild esophagitis 
Severe chronic 
gastritis 
80 566 
53 77 f no positive positive positive Severe active 
chronic gastritis 
101 <100 
54 27 m s positive positive positive Severe active 
chronic gastritis 
99 120 
55 37 m no positive positive positive Severe active 
chronic gastritis 
75 1088 
56 18 f no positive positive positive mild chronic gastritis 83 378 
57 42 f no negative negative negative Severe active 
chronic gastritis 
81 264 
58 41 f no negative negative negative Severe active 
chronic gastritis 
80 261 
59 28 m s positive positive positive Severe active 
chronic gastritis 
103 100 
60 35 f no positive positive positive Severe active 
chronic gastritis 
95 152 
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Figure 1. Histogram showing the frequency distribution for age in all patients 
screened for Helicobacter pylori. 
 
Out of the total patients enrolled in this study tests, 43 were positive 
for Helicobacter pylori giving a percentage of 72%. The results 
indicated that 25 males (25/31) were positive for Helicobacter pylori 
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giving a percentage of 81%. Among the female population there was 
18 (18/29) positive for Helicobacter pylori giving a percentage of 
62%. With reference to the total population tested, there were 25 
males (25/43) positive for Helicobacter pylori giving a percentage of 
58%. Furthermore, there were 18 females (18/43) out of the positive 
population positive for Helicobacter pylori giving a percentage of 
42%.  With respect to smoking, the number of smokers was 11 
(11/43) out of the total number of patients positive for Helicobacter 
pylori, giving a percentage of 26%. These results are shown in Table 2 
 
 
 
 
Parameter 
Evaluated 
Total Number 
Positive 
Number 
Positive 
Number 
Negative 
Percent 
Positive (%) 
 
Male 
 
43 
 
25 
 
6 
 
58% 
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Female 
 
43 
 
 
18 
 
11 
 
42% 
Age: 
 Grp 1 (20-40) 
Grp 2 (40-60) 
Grp 3 (>60) 
 
43 
 
24 
8 
11 
 
8 
6 
3 
 
56% 
19% 
26% 
 
Smoker 
 
43 
 
11 
 
49 
 
18% 
Table 2. Distribution of the positive patients for Helicobacter pylori infection 
with respect to gender, age and smoking. 
The relationship between MCV and vitamin B12 was evaluated in this 
study. In megaloblastic anemia, MCV was determined to be >90 fl 
and vitamin B12 <250 pg/ml. Our results revealed that 29 patients out 
of the total positive patients (29/43) have MCV above 90 fl, giving a 
percentage of 67%. With respect to vitamin B12, there were 31 
patients out of the positive ones (31/43) have levels <250 pg/ml, 
giving a percentage of 72%. These results are shown in Table 3. 
 
 
Number of patients 
MCV 
(>90 fl) 
Vitamin  B12 
<250 pg/ml 
 
Positive 
 
 
29 
 
31 
   
  
62  
 
 
Total Positive 
 
43 43 
 
Percentage Positive 
 
 
63% 
 
72% 
Table 3. Relationship between vitamin B12 deficiency and elevated MCV in 
patients with Helicobacter pylori infection. 
 
In this study we compared the test results for invasive methods (CLO 
test and pathology) with non invasive methods (serology). All the 
results obtained were actually identical. All patients with Helicobacter 
pylori infection were positive with CLO test, rapid signal serology test 
and the histopathology results. The results are summarized in Table 4. 
 
 
 
 
Test 
 
Total Number 
of Patients  
 
 
Positive 
 
 
Negative 
 
 
Percent Positive 
(%) 
 
CLO 
 
 
60 
 
43 
 
17 
 
100% 
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Rapid Signal Test 
(Serology) 
 
 
60 
 
43 
 
17 
100% 
 
Histopathology 
 
 
60 
 
43 
 
17 
100% 
Table 4. Comparison between the different testing methods with respect to 
Helicobacter pylori infection. 
 
 
 
 
 
 
Discussions  
Helicobacter pylori infection in developing countries was reported to 
be (70%-90%) 
(9)
. our results fall within this range. Replogle reported 
that male sex can be considered as a risk factor 
(10)
. Our results 
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showed that 25 male patients (58%) were positive for Helicobacter 
pylori but our study results may be suggestive that male sex could be 
a potential risk factor for Helicobacter pylori infection. On the other 
hand, male sex can not be a conclusive risk factor (P=0.606). 
It is apparent from the results obtained that smoking has no effect on 
the acquisition of Helicobacter pylori. There were 30 non-smoking 
patients (70%) out of all those diagnosed with Helicobacter pylori 
infection Table (2). This is a reliable conclusion, since the acquisition 
of Helicobacter pylori occurs at childhood where the great majority of 
the population is non-smokers. Comparing the different methods for 
diagnosing Helicobacter pylori, there was complete agreement 
between histopathology, CLO-test and serology. There was no 
significant difference between CLO test and histpathological results 
when paired t-test was applied (P <0.05) Table (4). 
Vitamin B12 deficiency or pernicious anemia is characterized by 
enlarged red blood cells and elevated MCV 
(44)
. Vitamin B12 or 
cobalamin deficiency occurs frequently (> 20%) among elderly people 
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(44)
. The causes of such deficiency are attributed to malabsorption, 
pernicious anemia and insufficient dietary intake
 (44)
. Therefore, the 
choice of patients for our study was restricted to those who are 
symptomatic with Helicobacter pylori infection only. Patients with 
malabsorption syndrome, pernicious anemia without Helicobacter 
pylori infection and patients suffering from malnutrition were 
excluded from our study.  Our results showed that 62.8% of all 
positive cases have elevated MCV and 72.1% have Vitamin B12 
deficiency. 
Our study as well as other studies focuses on the changes that takes 
place in the gastric environment. The tropism of Helicobacter pylori 
to survive the highly acidic environment of the stomach significantly 
contributes to the pathological changes of the gastric mucosa
 (36)
. The 
first line of defense for this organism is to neutralize the acidity of the 
stomach by the production of ammonia
 (35)
. In the absence of 
chronicity of the infection, neutralizing the acid environment in the 
stomach will definitely impair the binding of the intrinsic factor to its 
epitope on vitamin B12-R
 (44)
. Consequently, the subsequent 
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absorption of vitamin B12 can be affected by lowering the levels of 
this vitamin without the development of deficient state
 (44)
. 
Chronic active gastritis causes the destruction of the parietal cells that 
produces the intrinsic factor. In the absence of the intrinsic factor, 
vitamin B12 deficiency will ensue once the storage pool of this 
vitamin is depleted
 (51)
.   
Other theories to explain the development of vitamin B12 deficiency 
takes advantage of the existence of Lewis blood group antigens on 
Helicobacter pylori. The immune system produces antibodies (IgG) 
against these antigens. Lewis blood group is also expressed on the 
parietal cells. This may lead to the evolution of autoimmunity against 
parietal cells. Eventually, they will be destroyed and consequently the 
mal-absorption syndrome will develop
 (64)
. 
Patients suffering from heart burn due to increased acidity of the 
stomach, tend to take medications such as ranitidine and others to 
alleviate the symptoms. The potential danger of such action is the 
reduction of acidity of the stomach. As mentioned previously, this 
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may have deleterious effects on the binding of the intrinsic factor to 
vitamin B12-R. The outcome of this will be a reduction of vitamin 
B12 levels. This condition will amplified by the presence of 
Helicobacter pylori infection. Both will rapidly cause the 
development of vitamin B12 deficiency. Diagnosis of Helicobacter 
pylori by serology is not helpful. It cannot differentiate between 
recently acquired infection and a chronic one. Considering the high 
rate of infection by Helicobacter pylori in developed countries
(50)
., 
and further higher rates in developing countries, the results of 
serological tests will not contribute much to the diagnosis of active 
infection 
(51)
 .  
Reviewing the complete blood count (CBC), the MCV was found to 
be elevated in all cases of Helicobacter pylori. This means that the 
patient is suspected of having megaloblastic anemia. Following the 
MCV results here will be logical to evaluate vitamin B12. Now in our 
study we followed strict criteria to select our patients. All our patients 
have no inherent problems related to vitamin B12 absorption and they 
are not suffering from malnutrition. This will lead us to consider the 
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possibility of Helicobacter pylori infection. Here, in addition to the 
gastritis and other related symptoms, the physician will not feel 
pressured to perform the ultimate invasive procedures, gastric and 
duodenal biopsies.  The number of patients in our study is not enough 
to conclusively extract this conclusion, but it definitely points to it.  
Histopathology is considered to be the gold standard for diagnosing 
Helicobacter pylori infections. Our study addressed the significance 
of this important test by performing histopathology on all patients of 
the study. In addition, vitamin B12 was determined for all the patients 
29(67%) of positive Helicobacter pylori infection 43, (72.%) had 
vitamin B12 level <200). Statistical analysis using SPSS paired t-test 
(2 tailed and <0.05 level of significance) revealed no significant 
difference between those two important parameters for infection with 
Helicobacter pylori. Considering that our variables in the study were 
restricted only to patients with Helicobacter pylori infection, and 
considering the reduction in vitamin B12 values, we can assume that 
there must be a correlation between the two. Our hypothesis is built 
on the assumption that Helicobacter pylori can be a potential 
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causative agent for vitamin B12 deficiency. It is a plausible theory 
with suggestive results. The only risk to adopt this conclusion in my 
opinion is the sample size. Our recommendation for future studies will 
be the following: 
-To increase the sample size 
-To determine the reference levels for vitamin B12 for the Palestinian 
population. This will make our interpretation of the results obtained 
more accurate. 
-Our results indicate that 19% of the patients have vitamin B12 levels 
between 200 – 250 pg/ml. Follow up on these patients may prove the 
possibility of developing deficiencies for vitamin B12. 
-Coproantigens for Helicobacter pylori can be detected in the stool of 
patients. It is not an invasive technique as compared to gastric 
biopsies. This test can be used to augment or clarify the results of 
serological tests. 
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A study like this should not be left without follow up. All 
Helicobacter pylori infected patients are usually treated with triple 
therapy according to predetermined therapeutic protocols. It will add a 
great value to this study to follow these patients and evaluate their 
vitamin B12 and MCV at least 6 months post therapy. 
The outcome of this study is in accordance with our theory. In the 
absence of other interfering factors, such as old age, mal-absorption, 
malnutrition, pregnancy, liver disease, Helicobacter pylori can be 
considered as potential causative agent of vitamin B12 deficiency. 
   References  
1. Martin J. Blaser. An endangered species in the stomach, pages3-9. 2005. 
2. Marshall, BJ., and Warren, JR. Unidentified curved bacilli on gastric 
epithelium in active chronic gastritis. Lancet I pages6-10, 1983. 
3. Marshall, BJ., and Warren, JR.  Unidentified curved bacilli in the stomach of 
patients with gastritis and peptic ulceration. Lancet pages17-26, 1984 
4. Andre Dubois, Spiral Bacteria in the Human Stomach: The Gastric 
Helicobacters. Emerging Infectious Diseases Vol. 1, No. 3 pages8-16, 1995. 
5. Hardin, F.J. and Wright, F.A. Helicobacter pylori: Review and Update. 
Hospital Physician, pages29-33. 2002. 
  
71  
 
 
6. Jones DM., Campylobacter-like organisms on the gastric mucosa: culture, 
histological and serological studies. J. Clin. Pathol, pages37-56. 1984. 
7. Warren, JR., and Marshall, BJ. Unidentified curved bacilli or gastric epithelium 
in active chronic gastritis. Lancet i, pages16-20. 1983. 
8. Dunn, BE. Helicobacter pylori. Clinical Microbiology Reviews  . Vol. 10, No. 
4. pages30-39 1997. 
 
9. Taylor, DN. and Parsonnet, J. Epidemiology and natural history of H. pylori 
infections.  M. J. Blaser, P. F. Smith, J. Ravdin, H. Greenberg, and R. L. Guerrant 
(ed.), Infections of the gastrointestinal tract. Raven Press, New York, N.Y. 
(Textbook) pages8-15.1995. 
10. Replogle, ML. Biologic sex as a risk factor for Helicobacter pylori infection in 
healthy young adults. Am. J. Epidemiol. 142, pages146-159. 1995. 
11.Malaty, HM., and Graham DY. Importance of childhood socioeconomic status 
on the current prevalence of Helicobacter pylori infection. Gut;35:pages742-
745.1994 
12. Thomas, JE., Isolation of Helicobacter pylori from human feces. Lancet 340 
pages326-332. 1992.  
13. Rowland, M. Low rates of Helicobacter pylori reinfection in children. 
Gastroenterology.117, pages16-191999. 
14. Megraud, F. Transmission of Helicobacter pylori: fecal-oral versusoral-oral 
route. Aliment. Pharmacol. Ther. 9, Suppl. 2. pages6-10 1995. 
15.  Klein, PD., Water source as risk factor for Helicobacter pylori infection in 
Peruvian children. Lancet 337. pages62-691991. 
 
16. Parsonnet, J. Fecal and oral shedding of Helicobacter pylori from healthy 
infected adults. JAMA, 282 pages28-29.1999. 
  
72  
 
 
17. Goodman KJ, Helicobacter pylori infection in the Colombian Andes: a 
population-based study of transmission pathways. Am J Epidemiol,144. pages6-
10 1996. 
18.Cave DR. Chronic gastritis and Helicobacter pylori. Semin Gastrointestinal 
Disease. 12. pages9-12 2001 
19.  Cohen H. Peptic ulcer and Helicobacter pylori. Gastroenterol Clin North Am.  
29. pages29-33 2000. 
20.  Xue, FB. Association of Helicobacter pylori infection with gastric carcinoma. 
A Meta analysis. World J Gastroenterol. Pages7-11, 2001 
21. Parsonnet, J.. Helicobacter pylori infection and gastric lymphoma. N Engl J 
Med  330, pages3-61994. 
22. Bayerdorffer, E. Regression of primary gastric lymphoma of mucosa-
associated lymphoid tissue type after cure of Helicobacter pylori infection. 
Lancet, 345 pages4-8. 1995. 
 
23. Benjamin, DG. Helicobacter pylori infection in children: recommendations for 
diagnosis and treatment. J. Pediatric Gastroenterology and Nutrition. 31. pages9-
12 2002.  
24. Handt,. Characterization of feline Helicobacter pylori strains and associated 
gastritis in a colony of domestic cats. J. Clinical Microbiology. 33. pages31-33 
1995. 
25. Klein, PD. Water source as a risk factor for Helicobacter infection in Peruvian 
children. Lancet. 337, pages19-221991. 
26. Grupel, P. Vector potential of houseflies (Musca domestica) for Helicobacter 
pylori. J. Clinical Microbiology. 35. pages1-3 1997. 
27. Eaton, KA. 1991. Essential role of urease in pathogenesis of gastritis induced 
by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59, pages8-12.1991. 
28. Mobley, H. L. T., M. D. Island, and R. P. Hausinger. Molecular biologyof 
microbial ureases. Microbiol. Rev. 59:pages451–480.1995 
  
73  
 
 
29. Smoot, DT.. Helicobacter pylori urease activity is toxic to human gastric 
epithelial cells. Infect. Immun. 58, pages6-101990. 
 
30. Lin, S. Intra-family transmission of H pylori infection. International J 
Gastroenterology. 3, pages3-41997. 
31. Armele, M.. Metabolism and genetics of Helicobacter pylori: the Genome Era. 
Microbiology and Molecular Biology Reviews. Vol. 63, No. 3 pages19-26, 1999. 
32. Johensans, Comparative ultrastructural and functional studies of Helicobacter 
pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA 
and FlaB, are necessary for full motility in Helicobacter species. J. Bacteriol. 177, 
pages11-13.1995. 
33. Geis, G.. Ultrastructure and biochemical studies of the flagellar sheath of 
Helicobacter pylori. J. Med. Microbiol. 38, pages30-331993. 
34. Ilver, D.. Helicobacter pylori adhesin binding fucosylated histo-blood group 
antigens revealed by retagging. Science. 279, pages40-46 1998.  
35. Tomb, JF., The complete genome sequence of the gastric pathogen 
Helicobacter pylori. Nature 388, pages350-361 1997. 
36. Odenbreit, S.,. Outer membrane proteins AlpA and AlpB are involved in H. 
pylori binding to epithelial cells. Gut 41, A107. pages105-119 1997. 
 
37. Yoshio, Y., Relationship between Helicobacter pylori iceA, cagA, and vacA 
status and clinical outcome: Studies in four different countries. J. Clinicl 
Microbiology, vol. 37, No. 7, 1 pages116-120999. 
38. Atherton, JC, The clinical and pathological importance of heterogeneity in 
vacA, encoding the vacuolating cytotoxin of Helicobacter pylori. 
Gastroenterology 112 pages136-139, 1996. 
39. Sebastian, S. and Michetti, P. Helicobacter pylori Infection. NEJM Medical 
Progress. vol. 347  No.15, pages55-592002. 
  
74  
 
 
40.Occhialini, A., Composition and gene expression of the cag 
pathogenicityisland in Helicobacter pylori strains isolated from gastric carcinoma 
and gastritis patients in Costa Rica. Vol. 69, No. 3,  pages3-6.2001.  
41. Kaptan, K.. Helicobacter pylori-is it a novel causative agent in Vitamin B12 
deficiency? Arch Intern Med, 160, pages12-16 2000. 
42. Gumurdulu, Y. Predictors of vitamin B12 deficiency: Age and helicobacter 
pylori load of antral mucosa. The Turkish Journal of Gastroenterology. Vol. 14, 
No.1, pages1-6 2003. 
43.  Perez-Perez, GI. Role of Helicobacter pylori infection in the development of 
pernicious anemia. Clin Infect Disease. 25, pages1-391997. 
44. Andres E,. Vitamin B12 (cobalamin) deficiency in elderly patients. Canadian 
Medical Association.  CMAJ, 171 (3), pages2-42004.  
 
45. Klee GG. Cobalamin and folate evaluation: measurements of 
methylmalonicacid and homocystein vs vitamin B12 and folate. Clin Chem, 46, 
2000.  
46. Eugenia, M. Comparitative study of urease tests for Helicobacter pylori 
detection in gastric biopsies. Rev Biomed; 10:145-151. 1999. 
47. NEJM 1997; 337:1441-8. 2) Br. J. Haematol 1997; 97: 695-700. 3) Am. J. 
Med. 1994; 96: 239-46. 4) Acta Haematol 1989; 81: 186-91. 5) Harrison’s, 14th 
Ed. 6) Cecil’s, 19th Ed pages6-10. 1997. 
48. Yüksel GÜMÜRDÜLÜ, Ender SERİN, Birol ÖZER, Fazilet 
KAYASELÇUK, Kemal KUL, Cengiz PATA, Mustafa GÜÇLÜ, Gürden GÜR, 
Sedat BOYACIOĞLU, Impact of h.pylori on the development of vitamin B12 
deficiency in absence of gastric atrophy. The Turkish Journal of 
Gastroenterology, Volume 14, No 1, Page(s) 44-49. 2003. 
49. Avcu N,Avcu Feta al. oral surgery:92: pages166-169,2001. 
50. Kür ad Kaptan, MD; Cengiz Beyan, MD; Kaptan, K.. Helicobacter pylori-is it 
a novel causative agent in Vitamin B12 deficiency? Arch Intern Med, 160, B12 
Deficiency?  Arch Intern Med;1 pages:1349-1353 . 2000  
 
  
75  
 
 
 51. David Loshak, Helicobacter Pylori Linked With Vitamin B12 
DeficiencyAmerican Journal of Gastroenterology, pages1-2611/02/2000. 
 
52. Brown, L.M. H. pylori: epidemiology and routes of transmission. Epidemiol. 
22(2): pages 283-297. Rev. 2002. 
53. Frenck, R.W. Jr. and J. Clemens. Helicobacter in the developing world. 
Microbes Infect. 5: pages705-713.2001. 
54. Shimoyama, T. Epidemiological study for infection with H. pylori in Japan 
compared with that in USA, Europe, and Asiuan Pacific area. Nippon rinsho. 
57(1) pages: 11-16. 1999. 
55. Naficey, A.B. Seroepidemiology of H. pylori infection in a population of 
Egyptian children. International Journal of Epidemiology; 29: pages 928-932, 
2000. 
56. Adams, BL. Survival of H. pylori in a natural fresh water environment. 
Applied Environmental Microbiology. vol. 69, No. 12, pages7462-7466. 2003. 
57. Degnan, AJ. Development of plating medium for selection of H. pylori from 
water samples. Applied Environmental Microbiology. vol. 69, No. 5, pages 2914-
18. 2003. 
58. Falsafi, T. Application of stool antigen test to evaluate the incidence of H. 
pylori infection in children and adolescents of Tehran, Iran. Clinical Diagnostic 
Laboratory Immunology. vol. 12, No. 9, pages1094-97. 2005. 
59. Suzuki, N. Production and application of new monoclonal antibodies specific 
for a fecal H. pylori antigen. Clinical and diagnostic Laboratory immunology. 
Vol. 9, No. 1, pages75-78.2003. 
60. Benoit, S., Maier, R. J. Dependence of Helicobacter pylori Urease Activity on 
the Nickel-Sequestering Ability of the UreE Accessory Protein, J. Bacteriol. 185: 
pages 4787-4795. 2003. 
 
61. Merkx-Jacques, A. The Helicobacter pylori flaA1 and wbpB Genes Control 
Lipopolysaccharide and Flagellum Synthesis and Function. J. Bacteriology, pages 
2253–2265 Vol. 186, No. 8, 2004. 
 
  
76  
 
 
62. Rasko, D. A., M. Keelan, T. J. Wilson, and D. E. Taylor. Lewis antigen 
expression by Helicobacter pylori. J. Infect. Dis. 184:pages315–321. . 2001 
63. Aspinall, G. O., M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran. 
Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 
43504): structure of the O antigen chain and core oligosaccharide regions. 
Biochemistry 35:pages 2489–2497. 1996. 
64. Lozniewski, A. Influence of Lewis antigen expression by Helicobacter pylori 
on bacterial internalization by gastric epithelial cells. Infection and Immunity, 
Vol. 71, No. 5, pages 2902–2906. , 2003  
65. Innocenti, M. Helicobacter pylori-Induced Activation of Human Endothelial 
Cells. Infection and Immunity, Vol. 70, No. 8. pages 4581–4590  . 2002 
 
66. Mahdavi, J.. H. pylori sabA adhesion in persistent infection and chronic 
inflammation. Science, vol. 297, pages 573-578. . 2002 
 
67. Guruge, J.L.. Epithelial attachment alters the outcome of Helicobacter pylori 
infection.  Proc Natl Acad Sci U S A;95:pages3925-3930. . 1998 
 
68. Lehours, P. Identification of a genetic marker of Helicobacter pylori strains 
involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. 
Gut 53:  pages931-937. 2004 
 
69. Yamazaki, S. Distinct Diversity of vacA, cagA, and cagE Genes of 
Helicobacter pylori Associated with Peptic Ulcer in Japan. J. Clin. Microbiol. 43:  
pages3906-3916.2005. 
 
70. Santos, A., New Pathogenicity Marker Found in the Plasticity Region of the 
Helicobacter pylori Genome. J. Clin. Microbiol. 41: pages1651-1655.2003. 
 
71. James Versalovic, J. Helicobacter pylori Pathology and Diagnostic Strategies. 
Am J Clin Pathol 119(3):pages 403-412. 2003. 
 
72. Uemura, N. Helicobacter pylori Infection and the Development of Gastric 
Cancer. The New England Journal of Medicine. Vol. 345, No. 11, pages784-789. . 
2001 
73.ROBERT C. OH, CPT, MC, USA, U.S. Army Health Clinic, Darmstadt, 
Germany DAVID L. BROWN, MAJ, MC, USA, Madigan Army Medical Center, 
  
77  
 
 
Fort Lewis, Washington, Vitamin B12 Deficiency,vol.67/no.5 pages2-
16(March,2003) 
74. KevinP.O'ReillyResidents'Report, Pernicious Anemia August17,pages 23-
26.1998  
 
